Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease

Abstract

This study provides Class IV evidence that for the majority of adults with Pompe disease, long-term ERT positively affects, or slows deterioration in, muscle strength, walking ability, and/or pulmonary function.